Home > Balance Sheet > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Total Liabilities

    Back to Balance Sheet
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Total Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Total Liabilities ₹416 Cr₹407 Cr₹378 Cr₹308 Cr₹184 Cr

What is the latest Total Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Total Liabilities ratio of SYNCOM FORMULATIONS (INDIA) is ₹416 Cr based on Mar2025 Consolidated results.
Year Total Liabilities
Mar2025₹416 Cr
Mar2024₹407 Cr
Mar2023₹378 Cr
Mar2022₹308 Cr
Mar2017₹184 Cr

How is Total Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?

Years Total Liabilities % Change
Mar2025 ₹416 Cr
2.18
Mar2024 ₹407 Cr
7.69
Mar2023 ₹378 Cr
22.58
Mar2022 ₹308 Cr
67.59
Mar2017 ₹184 Cr -

Compare Total Liabilities of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,254.9 Cr 0.5% -5.1% -25.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹467,630.0 Cr -1.5% 2.5% 14.5% Stock Analytics
DIVIS LABORATORIES ₹221,666.0 Cr 7.4% 22.2% 26.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹190,108.0 Cr 3.1% 4.3% 38.5% Stock Analytics
CIPLA ₹117,139.0 Cr -1.6% -1.4% -6.5% Stock Analytics
DR REDDYS LABORATORIES ₹97,990.9 Cr 1.5% -15.2% -9.1% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

0.5%

-5.1%

-25.3%

SENSEX

1.2%

0.4%

-2.9%


You may also like the below Video Courses